NIH #R01CA317052
Deciphering tumor heterogeneity, metastatic spread, and treatment resistance in advanced bladder cancer
Active
- Amount
- $700K–$800K
- Period
- 2026-07-02 → 2031-06-30
- PIs
- 2
Awarded at FRED HUTCHINSON CANCER CENTER
Full Professor(heuristic)
Cancer Genomics and Diagnostics · Cancer Research
Compare more Cancer Research professors.
h-index90
i10-index131
Publications388
Citations75,408
Grants
6 total · 3 active
NIH #R01HL183263
Molecular Profiling and Risk Assessment of Preeclampsia Using Cell-Free DNA
Active
- Amount
- $1M–$2M
- Period
- 2026-07-01 → 2031-04-30
- PIs
- 2
Awarded at UNIVERSITY OF WASHINGTON
NIH #R01CA280056
Evaluating prostate cancer phenotype and genotype classification from circulating tumor DNA as biomarkers for predicting treatment outcomes
Active
- Amount
- $500K–$600K
- Period
- 2023-09-19 → 2028-08-31
- PIs
- 2
Awarded at FRED HUTCHINSON CANCER CENTER
Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →
Recent Public Signals
- New NIH award: Deciphering tumor heterogeneity, metastatic spread, and treatment resistance in advanced bladder cancer2026-07-02
- New paper: Germline CDK12 variants in aggressive prostate cancer (Cancer Discovery)2026-07-02
- New NIH award: Molecular Profiling and Risk Assessment of Preeclampsia Using Cell-Free DNA2026-07-01
Are you this professor?
No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.
Data Freshness
- Publications as of 2026-07-09
- Grants as of 2026-08-26
Data may not be current
Find elsewhere
ORCID: 0000-0001-7578-7272